Lewy Body Disease

Lewy Body Disease, associated with abnormal deposits of proteins like alpha-synuclein in the brain, causes a decline in mental abilities. Here is the latest on this progressive neurological disorder.

July 31, 2020

Dopamine promotes the neurodegenerative potential of β-synuclein

Journal of Neurochemistry
Anupam RainaSebastian Kügler
July 28, 2020
Open Access

A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease

Journal of Clinical Medicine
Christine SerratriceMarc G Berger
August 10, 2020

The Relationship Between Dementia Subtypes and Nutritional Parameters in Older Adults

Journal of the American Medical Directors Association
Pinar SoysalAhmet Turan Isik
July 28, 2020
Open Access

Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase Inhibitor

International Journal of Molecular Sciences
Elizabeth Terry-KantorUlf Dettmer
August 5, 2020
Open Access

ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies

Acta Neuropathologica
David L DaiAlice S Chen-Plotkin
August 6, 2020
Open Access

Differential protein expression in diverse brain areas of Parkinson's and Alzheimer's disease patients

Scientific Reports
A R Esteves, S M Cardoso
August 7, 2020

Parasomnias Occurring in Non-Rapid Eye Movement Sleep

Continuum : Lifelong Learning in Neurology
Michael H Silber
August 2, 2020
Open Access

Modulating Disease-Relevant Tau Oligomeric Strains by Small Molecules

The Journal of Biological Chemistry
Filippa Lo CascioRakez Kayed
August 1, 2020

Effect of Dance on Postural Control in People with Parkinson's Disease: A Meta-Analysis Review

Journal of Aging and Physical Activity
Heloisa Suzano de AlmeidaElirez Bezerra da Silva
August 5, 2020

Euthanasia in patients with dementia

Nederlands tijdschrift voor geneeskunde
S van der Meer, B Keizer
August 8, 2020

RAB39B is redistributed in dementia with lewy bodies and is sequestered within Aβ plaques and lewy bodies

Brain Pathology
David J KossTiago F Outeiro
August 5, 2020
Open Access

The challenges of COVID-19 for people with Dementia with Lewy Bodies and family caregivers

International Journal of Geriatric Psychiatry
Alison KillenJohn-Paul Taylor
August 4, 2020

Residual Injurious Symptoms and Its Association with Neurodegenerative Outcomes in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: A Retrospective, Longitudinal Follow-Up Study

Movement Disorders : Official Journal of the Movement Disorder Society
Jing WangYun Kwok Wing
August 7, 2020

Rapid Eye Movement Sleep Behavior Disorder and Other Rapid Eye Movement Parasomnias

Continuum : Lifelong Learning in Neurology
Michael J Howell
August 4, 2020
Open Access

Differential Atrophy in the Hippocampal Subfield Volumes in Four Types of Mild Dementia

Frontiers in Neuroscience
Lin HuangQihao Guo
July 29, 2020

Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG imaging for Parkinson's Disease

Current Radiopharmaceuticals
Viviana FrantellizziGiuseppe De Vincentis
July 31, 2020

α-Synuclein in Parkinson's Disease: Does a Prion-Like Mechanism of Propagation from Periphery to the Brain Play a Role?

The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
Huimin ZhengYuming Xu
July 31, 2020
Open Access

BCAS1-positive immature oligodendrocytes are affected by the α-synuclein-induced pathology of multiple system atrophy

Acta Neuropathologica Communications
Seiji KajiRyosuke Takahashi
July 29, 2020
Review

Proteopathic Seed Amplification Assays for Neurodegenerative Disorders

Clinics in Laboratory Medicine
Natália do Carmo Ferreira, Byron Caughey

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/lewy-body-disease/d845e2c9-fe0c-494f-a546-cfdd61fc59d7